December 28, 2020
Contact tracing technologies and applications (CTT/CTAs) have become a great focus in the new norm of COVID-19. There are many ethical and validation challenges surrounding the uses of these technologies which have been in play before the pandemic and will continue after.
Maria Palombini, Director of Emerging Communities & Opportunities Development and Healthcare Life Sciences (HLS) Practice Lead at IEEE Standards Association (IEEE SA), interviews Ali Hessami, Innovation Director at Vegas Global Systems LTD and Chair and Technical Editor for IEEE P7000 Standards, about ethical considerations on contact tracing technologies and applications in order to mitigate spread of the pandemic and protect personal privacy and public.
December 21, 2020
Digital therapeutics are growing in popularity for patients. Combining science and technology creates a double-edge sword including one how to best establish quality and trust in the safety and efficacy of patients.
Maria Palombini, Director of Emerging Communities & Opportunities Development and Healthcare Life Sciences (HLS) Practice Lead at IEEE Standards Association (IEEE SA), Michael Ambrose, Director of Product Quality and Analytical Process at USP about establishing standards in digital therapeutics to assure quality and build trust with patients -- the core of the healthcare ecosystem.
December 15, 2020
In an effort to enhance clinical research, Maria Palombini, Director of Emerging Communities & Opportunities Development and Healthcare & Life Sciences (HLS) Practice Lead at the IEEE Standards Association (IEEE SA), interviews Jennifer Goldsack, Executive Director of Digital Medicine Society (DiME) to explore the need for bringing together pharmaceutical clinical researchers and technologists to compel device makers to embrace and develop open source and compatible technologies.
December 1, 2020
The newly released IEEE 2791-2020 Standard for Bioinformatics Analyses Generated by High-Throughput Sequencing (HTS) facilitates an expedited bioinformatics communications exchange protocol amongst critical stakeholders in the clinical research phase.
Maria Palombini, Director of Emerging Communities & Opportunities Development and Healthcare and Life Sciences (HLS) Practice Lead at IEEE Standards Association (IEEE SA), interviews Raja Mazumder and Jonathon Keeney to shine a spotlight on the many different use cases from submissions for FDA regulatory review, to potential COVID-19 antibody research and other vaccine and infectious disease development applications.
August 14, 2020
In the inaugural edition of the “IEEE Blockchain Podcast Series,” Alpesh Shah, Sr. Director, Global Business Strategy and Intelligence for IEEE, sits down with Dr. Bryant Gilot, MD, CMO of Blockchain Health Co., to discuss on what blockchain is, the practical applications on how it can be used, and what is needed to get us there.
Alpesh and Bryant will discuss the impact blockchain technologies will have on 21st century problems such as healthcare management, how the new General Data Protection Regulation (GDPR) may impact blockchain, and the ethical concerns of implementing blockchain.
Part 1 (10:34)
Dr. Bryant Gilot, MD and Blockchain Introduction
January 31, 2018
Groundbreaking Technology Key for Improving Clinical Studies, Unlocking and Securing Data and Enhancing Patient Safety and Engagement. Learn more about the Blockchain for Clinical Trials Forum.
October 13, 2017
Counterfeit medicine is a rapidly rising global epidemic. The size and scope of the issue are reaching a point where the World Health Organization can only roughly estimate that the number of counterfeit meds in the market range from 10-30%. In this latest Blockchain Podcast Series episode, you’ll hear from Carlos Sanchez and Robert Panetta from BlockRx on how the BlockRx Pharma ecosystem is addressing this issue.